Investigator-initiated studies: Challenges and solutions
Investigator-initiated studies (IISs) help by generating data on effectiveness and safety of a drug in the real-world setting and attempt to answer questions that clinicians face in their day-to-day practice. These are studies that are initiated and managed by a nonpharmaceutical company researcher/...
Main Authors: | Mahanjit Konwar, Debdipta Bose, Nithya J Gogtay, Urmila M Thatte |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Perspectives in Clinical Research |
Subjects: | |
Online Access: | http://www.picronline.org/article.asp?issn=2229-3485;year=2018;volume=9;issue=4;spage=179;epage=183;aulast=Konwar |
Similar Items
-
Regulatory requirements for clinical trials in India: What academicians need to know
by: Nithya J Gogtay, et al.
Published: (2017-01-01) -
Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators
by: Brinal Figer, et al.
Published: (2021-01-01) -
An audit of studies registered retrospectively with the Clinical Trials Registry of India: A one year analysis
by: Amit R Birajdar, et al.
Published: (2019-01-01) -
Valbenazine: Drug review
by: Mahanjit Konwar, et al.
Published: (2017-01-01) -
The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal
by: Sujeet Rajan, et al.
Published: (2020-01-01)